Location: Seattle, WA
Cap-Exempt H-1B Position — No lottery required
Overview: Fred Hutchinson Cancer Center is an independent, nonprofit organization providing adult cancer treatment and groundbreaking research focused on cancer and infectious diseases. Based in Seattle, Fred Hutch is the only National Cancer Institute-designated cancer center in Washington. With a track record of global leadership in bone marrow transplantation, HIV/AIDS prevention, immunotherapy and COVID-19 vaccines, Fred Hutch has earned a reputation as one of the world’s leading cancer, infectious disease and biomedical research centers. Fred Hutch operates eight clinical care sites that provide medical oncology, infusion, radiation, proton therapy and related services, and network affiliations with hospitals in five states. Together, our fully integrated research and clinical care teams seek to discover new cures to the world’s deadliest diseases and make life beyond cancer a reality. At Fred Hutch we value collaboration, compassion, determination, excellence, innovation, integrity and respect. Our mission is directly tied to the humanity, dignity and inherent value of each employee, patient, community member and supporter. Our commitment to learning across our differences and similarities make us stronger. We seek employees who bring different and innovative ways of seeing the world and solving problems. The **Clinical Research Coordinator I or II** (CRC) will be responsible for clinical trial coordination activities including participant enrollment, data collection and storage, participant communication, and interfacing with the larger study team. The CRC also supports all administrative and day-to-day trial operations. This individual will work under the supervision of the Principal Investigator, Project Manager, and Staff Scientist and will be required to perform their responsibilities with a high level of independence within the scope of study protocol(s) and institutional policies and guidelines. The CRC also supports outreach, engagement, and patient-fa